InSphero is a pioneering brand that specializes in advancing drug discovery through the use of innovative 3D cell-based technology and organ-on-a-chip platforms. With a focus on enabling the delivery of life-saving therapies to patients worldwide, InSphero offers a range of products and services that provide scalable, robust, and physiologically relevant in vitro insights. Their 3D InSight™ platforms and microtissue formats allow for the creation of realistic 3D cell cultures that mimic human biology, making them ideal for applications such as liver toxicology, metabolic disease research, oncology efficacy testing, and immuno-oncology studies.

Additionally, InSphero offers specialized products like ARCTis™ for cryopreservation and assay-ready tumor models for custom tumor model development. Complementing their product offerings, InSphero provides a comprehensive suite of services, including in vitro toxicology studies, mechanistic and investigative studies, drug discovery services for diabetes and NASH, as well as efficacy testing and combinatorial drug testing. With a strong commitment to advancing understanding and generating actionable insights, InSphero's interdisciplinary team remains dedicated to the rapid and safe discovery of life-saving drugs for life-threatening diseases